This site is intended for healthcare professionals only
LoginRegister
Dr Reddys Partner Immutep Halts Phase III Trial of Eftilagimod Alfa in Lung Cancer StudyDr Reddy's Labs recalls epilepsy drug in US over infusion bag mislabeling
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer Finerenone secures USFDA Priority Review designation for heart failure
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentAstraZeneca to acquire EsoBiotec for up to USD 1 billion
Dr Reddys, Zydus recall products in US over manufacturing issuesSun Pharma, Zydus recall products in US over manufacturing issues
USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoeaUSFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoea
Lupin bags tentative USFDA nod for rare autoimmune disorder drug AmifampridineLupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine
AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancerAstraZeneca Imfinzi approved in EU for limited stage small cell lung cancer
Dr Reddys Partner Immutep Halts Phase III Trial of Eftilagimod Alfa in Lung Cancer StudyDr Reddy's Laboratories gets CDSCO Panel nod to study Rabeprazole Sodium Modified Release Capsules
Novartis AG to Exit India Arm in Rs 1,446 Cr Deal, ChrysCapital-Led Consortium Buys 70.68% StakeCDSCO Panel Approves Updated Package Insert for Novartis' Ofatumumab Injection
USFDA Flags Compliance Issues at Novo Nordisks New Jersey FacilityNo Long-Term Safety Data: CDSCO Panel Denies Novo Nordisk's proposal to amend warning statement of...
DoP organises Industry dialogue on PRIP Scheme in MumbaiDoP organises Industry dialogue on PRIP Scheme in Mumbai
Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone LymphomaBristol Myers Squibb gets European Commission nod for Breyanzi for follicular lymphoma
X